Team
health

Padua Score Calculator

The Padua score quantifies venous thromboembolism (VTE) risk in hospitalized or acutely ill patients by evaluating key clinical factors. Physicians use this evidence-based tool to determine whether anticoagulant prophylaxis is warranted, balancing protection against clot formation against bleeding risk. A score of 4 or higher typically indicates need for pharmacological prevention.

Last updated:

Creators Małgorzata Koperska, MD
375 people find this calculator helpful

Understanding Venous Thromboembolism

Venous thromboembolism encompasses deep vein thrombosis (DVT), pulmonary embolism (PE), and cerebral venous sinus thrombosis. These conditions arise when blood clots form in veins, potentially causing limb swelling, chest pain, or neurological complications. Virchow's triad—stasis, endothelial injury, and blood coagulability changes—explains the underlying mechanism.

DVT classically presents as a swollen, warm, painful leg, often unilateral. Pulmonary embolism occurs when a clot travels to lung vessels, causing shortness of breath and chest discomfort. Hospitalization, immobility, cancer, and surgery substantially elevate risk. Prompt recognition and risk stratification prevent serious morbidity and mortality.

Padua Score Calculation

The Padua score adds weighted points for clinical and demographic factors. Each variable contributes 0 (absent) or a specific positive value. Scores range from 0 to 20+. Clinical interpretation typically classifies scores below 4 as low-risk and 4 or above as requiring thromboprophylaxis consideration.

Padua Score = Age + Obesity + Reduced Mobility + Hormonal Treatment + Active Cancer + Trauma/Surgery + Previous VTE + Thrombophilic Condition + Failure + Myocardial Infarction + Infection

Age ≥70 years: 1 point | <1 point

Obesity (BMI ≥30): 1 point | <1 point

Reduced mobility: 3 points | <3 points

Hormonal treatment: 1 point | <1 point

Active cancer: 3 points | <3 points

Trauma/surgery (≤1 month): 2 points | <2 points

History of VTE: 3 points | <3 points

Thrombophilic condition: 3 points | <3 points

Heart/respiratory failure: 1 point | <1 point

Myocardial infarction or stroke: 1 point | <1 point

Infection/rheumatologic disease: 1 point | <1 point

  • Age — Patient age in years; ≥70 years adds 1 point
  • Obesity — Body mass index ≥30 kg/m²; adds 1 point if present
  • Reduced mobility — Confinement to bed or chair; adds 3 points
  • Hormonal treatment — Estrogen therapy, oral contraceptives, or HRT; adds 1 point
  • Active cancer — Ongoing malignant disease or recent chemotherapy; adds 3 points
  • Trauma/surgery — Major trauma or surgery within 1 month; adds 2 points
  • Previous VTE — History of DVT, PE, or Budd-Chiari syndrome; adds 3 points
  • Thrombophilic condition — Factor V Leiden, antiphospholipid syndrome, prothrombin mutation; adds 3 points
  • Failure — Heart or respiratory failure; adds 1 point
  • Myocardial infarction — Recent MI or ischemic stroke; adds 1 point
  • Infection — Active infection or rheumatologic disease; adds 1 point

Risk Assessment and Clinical Decision-Making

VTE risk assessment begins with identifying patient factors before selecting preventive strategies. Clinicians evaluate hemodynamic stability, renal function, bleeding contraindications, and recent anticoagulation history. D-dimer testing, compression ultrasound, and imaging confirm suspected thrombosis rather than guide prophylaxis decisions.

A Padua score of 4 or higher generally warrants thromboprophylaxis unless active bleeding or severe thrombocytopenia exists. Lower-risk patients may benefit from early mobilization and mechanical measures alone. Risk factors are cumulative; a patient with cancer, immobility, and prior VTE accumulates points rapidly, necessitating aggressive prevention.

Prophylaxis Methods: Pharmacological and Mechanical

Pharmacological options include low-molecular-weight heparin (LMWH), unfractionated heparin (UFH), vitamin K antagonists, and direct oral anticoagulants (DOACs). LMWH is most commonly used during hospitalization due to predictable pharmacokinetics and subcutaneous dosing convenience.

Mechanical prophylaxis comprises compression stockings, intermittent pneumatic compression (IPC) devices, leg elevation, and early ambulation. These methods reduce venous stasis without systemic anticoagulation and are often combined with pharmacological approaches, especially post-operatively or in high-risk populations.

Choice depends on bleeding risk, renal function, duration of immobility, and institutional protocols. Mechanical methods alone are insufficient for scores ≥4 unless anticoagulation is absolutely contraindicated.

Clinical Pitfalls and Considerations

Applying the Padua score requires attention to nuance and individual context.

  1. Weighing bleeding versus clotting risk — A high Padua score does not automatically mandate anticoagulation if active bleeding, severe coagulopathy, or recent intracranial hemorrhage is present. Risk-benefit discussions with the clinical team are essential. Some patients tolerate mechanical prophylaxis alone temporarily.
  2. Defining reduced mobility accurately — Immobility must be documented: bed rest, chair confinement, or inability to walk without assistance. Patients walking to the bathroom or moving freely should not receive 3 points. Misclassification inflates scores and may lead to unnecessary treatment.
  3. Remembering temporal limits on risk factors — Trauma or surgery points apply only within 1 month. Once that window closes, those points no longer count. Similarly, infection scores apply during active disease; resolving infection reduces risk. Recalculate periodically as clinical status evolves.
  4. Avoiding prophylaxis duration errors — Thromboprophylaxis should continue throughout hospitalization and immobility, not just for a fixed interval. Extended prophylaxis (2–10 days post-discharge) may be appropriate after major surgery or cancer-related hospitalization. Follow clinical practice guidelines relevant to your setting.

Frequently Asked Questions

What is a high Padua score, and when do I need to start prophylaxis?

A Padua score of 4 or above generally indicates moderate to high VTE risk and suggests pharmacological prophylaxis should be considered unless contraindicated by active bleeding or severe coagulopathy. Scores below 4 typically correspond to low risk, and mechanical measures—such as early mobilization, leg exercises, and compression—may suffice. Individual institutional protocols and clinical judgment remain paramount; discussion with your medical team ensures the decision aligns with the patient's overall health status.

Can mechanical prophylaxis alone prevent blood clots in high-risk patients?

Mechanical prophylaxis reduces venous stasis and is an important first-line intervention, particularly immediately post-operatively or when anticoagulation is unsafe. However, for Padua scores ≥4, mechanical methods alone are generally insufficient. Combining compression stockings or intermittent pneumatic compression with pharmacological prophylaxis provides superior protection. Exclusively mechanical approaches are reserved for patients with absolute anticoagulation contraindications and require close clinical surveillance.

How often should the Padua score be recalculated during a hospital stay?

Reassess the score when clinical circumstances change: if a patient becomes mobile, infection resolves, cancer treatment concludes, or heart failure is corrected, points may decrease, potentially lowering the overall score. Conversely, new complications such as acute MI or hospital-acquired infection warrant recalculation. Many protocols recommend reassessment at hospital day 3–5 and whenever significant status changes occur to adjust prophylaxis intensity appropriately.

Are patients with prior DVT or PE automatically high-risk?

Yes. History of venous thromboembolism adds 3 points to the Padua score, reflecting approximately 5–10% recurrence risk annually without prophylaxis. Patients with prior VTE combined with additional risk factors (age, immobility, cancer) accumulate points rapidly and warrant aggressive prophylaxis. Secondary prevention with anticoagulation is often continued longer post-discharge in these individuals compared to those with first-time thrombosis.

Does the Padua score apply to all hospitalized patients?

The Padua score was developed and validated for acutely ill, hospitalized medical patients, including those with infection, heart failure, and malignancy. It performs well in this population. However, it is not typically used for post-operative surgical patients, who have separate risk-stratification tools and prophylaxis guidelines. Always confirm that your clinical setting and patient population align with the evidence base for the Padua score.

What role does D-dimer testing play alongside the Padua score?

D-dimer is used to diagnose suspected VTE—elevated levels support the need for imaging confirmation. The D-dimer test does not guide thromboprophylaxis decisions; the Padua score does that. D-dimer screening of asymptomatic, low-risk patients is not recommended due to high false-positive rates. Use D-dimer clinically when VTE symptoms are present or when clinical suspicion is high, combined with imaging to confirm diagnosis.

More health calculators (see all)

BMR Harris-Benedict Equation Calculator IV Flow Rate Calculator SAPS II Calculator Drip Rate Calculator Sodium Correction Rate Calculator RBC Indices Calculator BUN/Creatinine Ratio Calculator Warsaw Method Calculator